These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2434775)

  • 1. Cardiovascular effects of vasopressin: some recent aspects.
    Liard JF
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S61-5. PubMed ID: 2434775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
    Liard JF
    Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs.
    Schwartz J; Liard JF; Ott C; Cowley AW
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H1001-8. PubMed ID: 3840655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does vasopressin-induced vasoconstriction persist during prolonged infusion in dogs?
    Liard JF
    Am J Physiol; 1987 Apr; 252(4 Pt 2):R668-73. PubMed ID: 3565599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs.
    Liard JF; Spadone JC
    J Cardiovasc Pharmacol; 1984; 6(4):713-9. PubMed ID: 6206331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intra-arterial arginine-vasopressin infusions on peripheral blood flows in conscious dogs.
    Liard JF
    Clin Sci (Lond); 1986 Dec; 71(6):713-21. PubMed ID: 3791873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.
    Jover B; Dupont M; Mimran A; Woods R; McGrath B
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H763-9. PubMed ID: 2889370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs.
    Liard JF; Dériaz O; Schelling P; Thibonnier M
    Am J Physiol; 1982 Nov; 243(5):H663-9. PubMed ID: 7137358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vasoregulation by arginine vasopressin in conscious, halothane-anesthetized, and pentobarbital-anesthetized dogs with increased vasomotor tone.
    Trempy GA; Nyhan DP; Murray PA
    Anesthesiology; 1994 Sep; 81(3):632-40. PubMed ID: 8092510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vasopressin in cardiovascular regulation.
    Cowley AW; Quillen EQ; Skelton MM
    Fed Proc; 1983 Dec; 42(15):3170-6. PubMed ID: 6641951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the vasoconstrictor and antidiuretic activities of vasopressin in inhibition of renin secretion in conscious dogs.
    Schwartz J; Reid IA
    Am J Physiol; 1986 Jan; 250(1 Pt 2):F92-6. PubMed ID: 3510566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer W
    J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of vasopressin as a pressor agent.
    Hofbauer KG; Studer W; Mah SC; Michel JB; Wood JM; Stalder R
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S429-38. PubMed ID: 6206352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J; Reid IA
    Neuroendocrinology; 1986; 42(2):93-6. PubMed ID: 3005898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
    Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
    Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.